
Specialty
Certifications
Hematology
American Board of Internal Medicine
Education
MD, Sackler Sch. of Med. Tel Aviv Univ
Residency, Internal Medicine
S.U.N.Y., Downstate Medical CenterResidency, Internal Medicine
S.U.N.Y., Health Science CenterFellowship, Oncology
Veterans Administration Med. Ctr.Fellowship, Hematology
Mount Sinai Hospital
Awards
2000 -
Excellence in Teaching Award
Mount Sinai School of Medicine2000 -
Dept of Medicine Housestaff Appreciation Award
Mount Sinai School of Medicine
Publications
Najfeld V, Burnett W, Vlachos A, Scigliano E, Isola L, Fruchtman S. Interphase FISH analysis of sex mismatched BMT utilizing dual color XY probes. Bone Marrow Transplant 1997; 19: 829-834.
Skerrett D, Rosina O, Gudozowaty O, Isola L, Scigliano E, Fruchtman S. Comparative Analysis of HLA-B*8101 by Serology, Isoelectric Focusing, and Sequence-Based Typing. Human Immunology 1999; 60: 168-170.
Matsushima AY, Strauchen J, Lee G, Scigliano E, Hale EE, Weisse MT, Burstein D, Kamel O, Moore PS, Chang Y. Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol 1999; 11: 1393-1400.
Isola L, Scigliano E, Fruchtman S. Long Term Followup After Allogeneic G-CSF Primed Bone Marrow Transplantation. Biol Blood Marrow Transplant 2000 ; 6: 428.
Clinical Trials
- A Phase II Study of Galixmab (Anti-CD80) for Patients with Relapsed/ Refractory Hodgkin's Lymphoma
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of the Safety, Tolerability, and Population Pharmacokinetics of CMX001 in Post-Transplant Subjects with BK Virus Viruria
Industry Relationships
Physicians and scientists on the faculty of Mount Sinai School of Medicine often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Scigliano did not report having any of the following types of financial relationships with industry during 2011 and/or 2012: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://www.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
19 East 98th Street Room 4C
New York, NY 10029
Fax: 212-410-0978

19 East 90th Street
Box 1410
New York, NY 10029
Fax: 212-410-0978


- Monday 9:00am - 1:00pm
- Tuesday 1:00pm - 5:00pm
- Wednesday 1:00pm - 5:00pm
- Friday 1:00pm - 5:00pm
- Spanish
- Aetna
- Beech Street
- Blue Choice
- Blue Cross/ Blue Shield
- Cigna
- Empire Blue Cross/Blue Shield
- First Health
- Medicaid
- Medicare
- Medicare Assignment
- Oxford Health Plans
- Private Healthcare Systems (PHCS)
- United Healthcare
- Master Card
- Visa
- American Express
- Personal Check
- Cash
1190 5th Avenue
Ruttenberg Treatment Center
New York, NY 10029



